bit.bio
BiotechnologyWebsite
Developer of a synthetic biology platform designed to provide human cells for research, drug discovery, and cell therapy. The company applies a patented safe-harbor gene-targeting approach to inducibl...
Valuation
$0
Share Price
N/A
Total Raised
$214.2M
Last Round
Later Stage VC
Dec 2021
Latest Funding Round
Later Stage VC
Dec 31, 2021
$138.3M
raised
Investors
+34 other investors